Newsroom.
New!
March 17, 2026
Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases
September 10, 2025
Innorna Completes Phase II Enrollment and Vaccination of Bivalent RSV mRNA Vaccine IN006
July 6, 2022
Innorna and BeiGene Announce Strategic Research Collaboration to Jointly Discover Novel mRNA Therapies